Investing.com - JCR Pharmaceuticals reported on Wednesday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
JCR Pharmaceuticals announced earnings per share of ¥-3.3 on revenue of ¥6.0. Analysts polled by Investing.com anticipated EPS of ¥-1.2 on revenue of ¥7.73B.
JCR Pharmaceuticals shares are down 16.97% from the beginning of the year, still down 28.85% from its 52 week high of ¥2,984.00 set on October 29, 2021.
JCR Pharmaceuticals follows other major Healthcare sector earnings this month
JCR Pharmaceuticals's report follows an earnings missed by Chugai Pharmaceutical on Monday, who reported EPS of ¥41.21 on revenue of ¥225.3B, compared to forecasts EPS of ¥49.44 on revenue of ¥288.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar